ImmunityBio, Inc. — Director's Dealing 2022

Jan 28, 2022

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: ImmunityBio, Inc. (IBRX)
CIK: 0001326110
Period of Report: 2021-12-31

Reporting Person: Thomas John C (Former Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-23	Common Stock	G	5000	—	Disposed	202477	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13886	Indirect

Footnotes

F1: Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.